Study: Viral emissions into the air and environment after SARS-CoV-2 human challenge: a phase 1, open label, first-in-human study.Image Credit: Kateryna Kon/Shutterstock.com Background ...

Test positivity for common cold coronaviruses significantly declined following widespread SARS-CoV-2 infection and COVID-19 ...

Estimates of SARS-CoV-2 Omicron BA.2 Subvariant Severity in New England. JAMA Network Open , 2022; 5 (10): e2238354 DOI: 10.1001/jamanetworkopen.2022.38354 Cite This Page : ...

Can mosquitoes ever carry and spread SARS-CoV-2, the virus that causes COVID-19? We asked the experts to weigh in. ... you’ll need to read the label and select the proper active ingredient. ...

Scientists have uncovered a stealthy tactic used by the SARS-CoV-2 virus: one of its proteins can leap from infected cells to ...

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, has an exceptional ability to overcome host defense barriers. It produces a set of specialized proteins ...

Since the start of the COVID-19 pandemic, there has been controversy surrounding the origins of SARS-CoV-2. New research from the University of California, San Diego (UCSD), School of Medicine ...

A new study uncovers a surprising mechanism by which the SARS-CoV-2 virus, responsible for COVID-19, might cause immune-mediated tissue damage by targeting cells it has never infected.

This cover art depicts SARS-CoV-2's novel immune escape strategy, where Spike-NTD binds with the host fibrinogen, shielding the virus from NTD-directed antibodies and facilitating immune evasion.

The presence of mRNA for SARS-CoV-2 N protein correlated with a significant increase in the inflammatory markers of NOD-like receptor family pyrin domain-containing 3 and tumor necrosis factor.